Comparing the Responsiveness of Barthel Index and Longshi Scale in Assessing the ADL of Stroke Survivors
Using Longshi Scale and Barthel Index to Evaluate the Ability of Daily Living Activities in Stroke Survivors: a Comparative Study
1 other identifier
observational
180
1 country
1
Brief Summary
The aim of this research was to compare the responsiveness of Barthel Index (BI) and Longshi Scale (LS) for assessing activities of daily living (ADL) in stroke survivors at different stage and we also aimed to observe changes of ADL score in stroke survivors over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedFirst Submitted
Initial submission to the registry
October 9, 2021
CompletedFirst Posted
Study publicly available on registry
December 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFebruary 6, 2023
April 1, 2021
8 months
October 9, 2021
February 3, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
The internal responsiveness of Longshi Scale at discharge
The internal responsiveness of Longshi Scale is described using standardized effect size (SES) and the standardized response mean (SRM). Score of SES and SRM ranges from 0 to 1. Higher SES or SRM means better outcomes and SES or SRM \> 0.5 is considered to be sufficient.
Baseline, 20 days after admission(discharge)
The internal responsiveness of Barthel Index at discharge
The internal responsiveness of Barthel Index is described using SES and SRM. Score of SES and SRM ranges from 0 to 1. Higher SES or SRM means better outcomes and SES or SRM \> 0.5 is considered to be sufficient.
Baseline, 20 days after admission(discharge)
The internal responsiveness of Longshi Scale at 3 months after discharge
The internal responsiveness of Longshi Scale is described using standardized effect size (SES) and the standardized response mean (SRM). Score of SES and SRM ranges from 0 to 1. Higher SES or SRM means better outcomes and SES or SRM \> 0.5 is considered to be sufficient.
Baseline, 3 months after discharge
The internal responsiveness of Barthel Index at 3 months after discharge
The internal responsiveness of Barthel Index is described using SES and SRM. Score of SES and SRM ranges from 0 to 1. Higher SES or SRM means better outcomes and SES or SRM \> 0.5 is considered to be sufficient.
Baseline, 3 months after discharge
Secondary Outcomes (8)
Pearson correlation coefficient (r) between Longshi Scale and Barthel Index at discharge
Baseline, 20 days after admission(discharge)
Pearson correlation coefficient (r) between Longshi Scale and Barthel Index at 3 months after discharge
Baseline, 3 months after discharge
Area under receiver operating characteristic curve of Longshi Scale at discharge
Baseline, 20 days after admission(discharge)
Area under receiver operating characteristic curve of Longshi Scale at 3 months after discharge
Baseline, 3 months after discharge
Area under receiver operating characteristic curve of Barthel Index at discharge
Baseline, 20 days after admission(discharge)
- +3 more secondary outcomes
Eligibility Criteria
Stroke survivors from the Department of Rehabilitation Medicine at Shenzhen Second People's Hospital are invited to participate in this study according to the inclusion and exclusion criteria.
You may qualify if:
- age 18-80 years
- diagnosis of cerebral infraction or intracerebral hemorrhage
- stable vital signs
You may not qualify if:
- brain tumor, Parkinson's disease or active epilepsy within three months
- impaired cognitive functions
- participation in any other clinical study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shenzhen Second People's Hospital
Shenzhen, Gunagdong, 518035, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 9, 2021
First Posted
December 9, 2021
Study Start
May 1, 2021
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
February 6, 2023
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share
Contact the principal investigator for data if necessary